The Research and Development team at Agendia is dedicated to advancing molecular diagnostics for breast cancer through innovative genomic testing. They focus on conducting clinical studies, analyzing data, and developing new assays to enhance understanding of breast cancer biology, ultimately aiming to improve patient outcomes and personalize treatment options.
View all